Segui
RAJESH SINGH
Titolo
Citata da
Citata da
Anno
Nanoparticle-based targeted drug delivery
R Singh, JW Lillard Jr
Experimental and molecular pathology 86 (3), 215-223, 2009
31842009
Challenges in liver cancer and possible treatment approaches
D Anwanwan, SK Singh, S Singh, V Saikam, R Singh
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188314, 2020
9102020
Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents
S Singh, SK Singh, I Chowdhury, R Singh
The open microbiology journal 11, 53, 2017
6122017
A review of sex estimation techniques during examination of skeletal remains in forensic anthropology casework
K Krishan, PM Chatterjee, T Kanchan, S Kaur, N Baryah, RK Singh
Forensic science international 261, 165. e1-165. e8, 2016
3222016
Past, present, and future technologies for oral delivery of therapeutic proteins
R Singh, S Singh, JW Lillard
Journal of pharmaceutical sciences 97 (7), 2497-2523, 2008
2312008
Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway
SK Singh, S Banerjee, EP Acosta, JW Lillard, R Singh
Oncotarget 8 (10), 17216, 2017
2032017
Drug delivery approaches for breast cancer
SK Singh, S Singh, JW Lillard Jr, R Singh
International journal of nanomedicine, 6205-6218, 2017
1952017
Inflammation, immunity, and cancer
R Singh, MK Mishra, H Aggarwal
Mediators of inflammation 2017, 2017
1722017
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
SK Singh, MK Mishra, IEA Eltoum, S Bae, JW Lillard, R Singh
Scientific reports 8 (1), 1-12, 2018
1582018
Morphological characterization of very small embryonic‐like stem cells (VSELs) by ImageStream system analysis
EK Zuba‐Surma, M Kucia, A Abdel‐Latif, B Dawn, B Hall, R Singh, ...
Journal of cellular and molecular medicine 12 (1), 292-303, 2008
1412008
miR 488* inhibits androgen receptor expression in prostate carcinoma cells
K Sikand, JE Slaibi, R Singh, SD Slane, GC Shukla
International Journal of Cancer 129 (4), 810-819, 2011
1402011
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication
UP Singh, C Venkataraman, R Singh, JW Lillard
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2007
1292007
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion
S Singh, R Singh, PK Sharma, UP Singh, SN Rai, LWK Chung, ...
Cancer letters 283 (1), 29-35, 2009
1012009
Effect of polyacrylamide on the different properties of cement and mortar
US Rai, RK Singh
Materials Science and Engineering: A 392 (1-2), 42-50, 2005
972005
CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion
C Johnson-Holiday, R Singh, E Johnson, S Singh, CR Stockard, ...
International journal of oncology 38 (5), 1279-1285, 2011
952011
Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer
S Banerjee, SK Singh, I Chowdhury, JW Lillard Jr, R Singh
Frontiers in bioscience (Elite edition) 9, 235, 2017
942017
Nanoparticles for delivery of active agents
JW Lillard, R Singh, S Singh
US Patent 8,568,784, 2013
942013
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
SK Singh, JW Lillard Jr, R Singh
Cancer letters 427, 49-62, 2018
852018
CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation
CP El‐Haibi, R Singh, PK Sharma, S Singh, JW Lillard Jr
Cell proliferation 44 (4), 311-319, 2011
842011
Bacterial contamination of frequently touched objects in a tertiary care hospital of Pokhara, Nepal: how safe are our hands?
DR Bhatta, D Hamal, R Shrestha, S Hosuru Subramanya, N Baral, ...
Antimicrobial Resistance & Infection Control 7, 1-6, 2018
812018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20